Macquarie Group Ltd. Buys Shares of 27,106 SeaSpine Holdings Corporation (SPNE)

Macquarie Group Ltd. bought a new position in SeaSpine Holdings Corporation (NASDAQ:SPNE) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 27,106 shares of the medical equipment provider’s stock, valued at approximately $304,000. Macquarie Group Ltd. owned 0.20% of SeaSpine at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Synovus Financial Corp purchased a new stake in shares of SeaSpine in the 2nd quarter worth $116,000. Virtu KCG Holdings LLC purchased a new stake in shares of SeaSpine in the 2nd quarter worth $133,000. Goldman Sachs Group Inc. purchased a new stake in shares of SeaSpine in the 2nd quarter worth $161,000. Schwab Charles Investment Management Inc. lifted its holdings in shares of SeaSpine by 1.0% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 18,707 shares of the medical equipment provider’s stock worth $216,000 after buying an additional 190 shares during the period. Finally, PDT Partners LLC purchased a new stake in shares of SeaSpine during the 2nd quarter worth $244,000. Institutional investors and hedge funds own 43.43% of the company’s stock.

Shares of SeaSpine Holdings Corporation (SPNE) opened at $10.05 on Monday. SeaSpine Holdings Corporation has a 12 month low of $6.31 and a 12 month high of $13.46.

A number of brokerages recently weighed in on SPNE. Ladenburg Thalmann Financial Services began coverage on SeaSpine in a research note on Thursday. They set a “buy” rating and a $20.00 price objective for the company. Zacks Investment Research upgraded SeaSpine from a “hold” rating to a “buy” rating and set a $12.00 price objective for the company in a research note on Wednesday, November 8th. BTIG Research restated a “buy” rating on shares of SeaSpine in a research note on Monday, November 6th. Piper Jaffray Companies restated a “buy” rating and set a $22.00 price objective on shares of SeaSpine in a research note on Sunday, August 20th. Finally, HC Wainwright restated a “buy” rating and set a $15.00 price objective on shares of SeaSpine in a research note on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $17.25.

COPYRIGHT VIOLATION NOTICE: “Macquarie Group Ltd. Buys Shares of 27,106 SeaSpine Holdings Corporation (SPNE)” was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://sportsperspectives.com/2017/12/18/macquarie-group-ltd-buys-shares-of-27106-seaspine-holdings-corporation-spne.html.

SeaSpine Profile

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.

Institutional Ownership by Quarter for SeaSpine (NASDAQ:SPNE)

Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply